Microdosing Research and Development Sleep 
United Patients Group
AUGUST 8, 2023
United Patients Group is dedicated to providing the latest information and research surrounding medical marijuana, empowering readers to make informed decisions about their health journey. In the sections that follow, we will delve deeper into the principles of microdosing medical marijuana.
Cannabis Law Report
JULY 13, 2022
The proposed phase I dosing study will aim to find the optimal microdose or low dose of psilocybin that provides general enhancements to mood, memory, sleep, and other measures of general well-being without any hallucinogenic effects. VANCOUVER, British Columbia, July 13, 2022 (GLOBE NEWSWIRE) — Optimi Health Corp. (
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Cannigma
JUNE 24, 2021
For instance when it comes to pain relief, THC and CBD have shown to be safer than opioids; and for anti-anxiety and sleep aids, CBD does not appear to be habit-forming like benzodiazepines. These natural alternatives may also be effective as part of a daily “microdosing” regiment. Meditation and mindfulness.
The Herb Collective
OCTOBER 12, 2023
The fascinating world of cannabis and its diverse effects on the human body have been a subject of extensive research and exploration. Tolerance to THC, the psychoactive component of cannabis, can develop over time, requiring users to consume larger quantities to achieve the desired effects.
Cannabis Law Report
AUGUST 10, 2022
Researchers will explore whether the psychoactive effects are necessary to relieve treatment-resistant depression in adults. It’s clear that alternative treatment options are necessary to combat depression and other mental illnesses, which is where companies developing psychedelic-based treatments like Optimi Health Corp.
SpeedWeed
MAY 8, 2021
Multinational tobacco conglomerate Philip Morris International recently announced that it is researching the possibility of getting involved in the legal weed industry. . Last week, Philip Morris CEO Andre Calantzopoulos told Bloomberg News that it was considering cannabis as a potential element of its new “Beyond Nicotine” strategy.
Cannabis Law Report
MAY 26, 2019
Happily they’ve seen remarkable results in their sons condition as they’ve researched the best strains for his condition and are working everyday to keep up with his evolving needs. PEOPLE WILL ASK: HOW DOES THIS BRAND RELATE TO ME and what condition I’m seeking to address, be it trouble eating / sleeping or if I just want to be happy.
Expert insights. Personalized for you.
98 
Let's personalize your content